Crossmark

Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study

Crossref DOI link: https://doi.org/10.1016/j.arbres.2025.11.005

Published Print: 2026-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cefalo, Jacopo

Varone, Francesco

Luppi, Fabrizio

Cameli, Paolo

Cerri, Stefania

Puci, Mariangela Valentina

Martini, Alessia

Franco, Giovanni

Zanini, Umberto

Pianigiani, Tommaso

Patsoura, Athina

Richeldi, Luca

Bargagli, Elena

Sotgiu, Giovanni

Mondoni, Michele
License Information

Text and Data Mining valid from 2026-06-01

Text and Data Mining valid from 2026-06-01
More Information

This article is maintained by: Elsevier

Article Title: Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2025.11.005

Content Type: simple-article

Copyright: © 2025 SEPAR. Published by Elsevier España, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Document is current

Any future updates will be listed below